CALL FOR ABSTRACT
Abstract submissions are open for healthcare professionals working or involved with haemophilia care in India.
Important Dates for Abstract Submissions
| Last date for Abstract submission/modification/withdrawal | 22nd May, 2026 |
| Notification of acceptance of abstracts | 15th June, 2026 |
Available topics:
The content of the abstract must be related to haemophilia and bleeding disorders under the following categories. The submitter can select the appropriate topic for each abstract submitted
- Clinical
- Laboratory
- Musculoskeletal
- Multi-disciplinary Care: Nursing, Dental, Psychosocial.
General Guidelines
- Abstracts must be informative, up to 300 words, excluding the title, author affiliations, and section headings (Aims, Methods, Results & Conclusions).
- A maximum of one table or graph in JPG format is allowed.
- Abstracts must describe original work at the time of submission. Case reports and case series are also encouraged.
- All Abstracts are subject to review by the Abstract Review Committee. Acceptance into the program is not guaranteed.
- Abstracts must be submitted online. Submissions via email, hard copy, or other modes will not be accepted.
- Abstracts must be submitted in English. Abstracts containing spelling, grammar, or scientific mistakes will be rejected. No proofreading will be conducted.
- The Abstract Review Committee reserves the right to reject Abstracts where inappropriate slicing of results into multiple Abstracts is suspected. Duplicate submissions under different topics will be rejected.
- Submitting an Abstract constitutes a formal commitment to present in person if accepted.
- Only healthcare professionals involved in haemophilia care may submit Abstracts.
Abstract Format and Submission Details:
Abstract Title
Write the title in sentence case without quotation marks. Example: *The results of the research study on ALL in India.*
Authors and Affiliations
- Corresponding/Submitting Author: The submitter will be the primary contact for all correspondence.
- Presenting Author: Enter details in the provided fields (even if the corresponding author is the same).
- Co-authors: The system allows up to 10 co-authors. For additional co-authors, contact the conference secretariat.
Abstract Text
The committee suggests the following format:
- Aims
- Methods
- Results
- Conclusions
- Key words
For Case Reports/Case Series: Use the headings below:
- Introduction (for Aims)
- Details of the case/cases (for Methods)
- Discussion (for Results)
- Conclusion (for Conclusion)
Conflict of Interest Statement
Indicate any commercial company involvement in the research. Use one of the following statements:
- No conflict of interest to disclose.
- This research was supported by [Company Name]. The company had no role in analysing the data or preparing the Abstract.
- This research was supported by [Company Name], which [describe the company’s role].
This statement is mandatory and will appear wherever the Abstract is published. For oral presentations, a disclosure slide will be required.
Important Note:
- If the Abstract is not submitted in the prescribed format, it will not be considered for review.
- The final decision of the Abstract review committee will be binding.
- More than 1 Abstract can be submitted by any individual/author.
- If an author as the presenting author is not able to present for the conference due to any reason, prior permission must be obtained from the Abstract Review Committee regarding the change in the presenting author.
After Submission
- The Abstract Review Committee will review all submissions. Each Abstract will be evaluated by 3 experts.
- Abstracts may be selected for oral presentations, poster presentation, or rejected.
- Only the presenting author will be notified of acceptance or rejection.
| Criteria | Description | Weightage |
|---|---|---|
| 1. Significance of the topic | Significant implications for haemophilia care, including new therapies or patient care improvements. | 5 |
| 2. Clarity of objectives | Clearly stated objectives following PICOTS. Congruence of Title, Aim & Conclusions. | 15 |
| 3. Methodological rigor & Scientific quality | Sound design, adequate sample size, statistical power, and well-supported conclusions. | 20 |
| 4. Originality/Novelty | Original research advancing knowledge in haemophilia. | 5 |
| 5. Relevance | Relevant to the country and its needs. | 5 |
Presentation Formats:
- The highest quality abstracts will be selected for an oral presentation.
- Oral Presentation: Presenting authors will receive details of the session date and time. In-person attendance is mandatory.
- Poster Presentation: Presenting authors must attend in person. No virtual presentations are allowed. Poster guidelines will be provided.
Certificates:
Oral Presentation Awards:
- The best oral presentation will be awarded with a "Best Presenter" e-certificate from each category.
- All other oral presenters will receive an oral presentation e-certificate.
Poster Presentation:
- The best poster presentation will be awarded with a "Best Presenter" e-certificate from each category.
- Abstracts selected for poster presentation will receive a poster participation e-certificate.
